These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17709147)

  • 21. Silver nanoparticles inhibit hepatitis B virus replication.
    Lu L; Sun RW; Chen R; Hui CK; Ho CM; Luk JM; Lau GK; Che CM
    Antivir Ther; 2008; 13(2):253-62. PubMed ID: 18505176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.
    Mani N; Cole AG; Phelps JR; Ardzinski A; Cobarrubias KD; Cuconati A; Dorsey BD; Evangelista E; Fan K; Guo F; Guo H; Guo JT; Harasym TO; Kadhim S; Kultgen SG; Lee ACH; Li AHL; Long Q; Majeski SA; Mao R; McClintock KD; Reid SP; Rijnbrand R; Snead NM; Micolochick Steuer HM; Stever K; Tang S; Wang X; Zhao Q; Sofia MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus].
    Wu JM; Lin JS; Xie N; Jiang FC; Liang KH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):268-70. PubMed ID: 12773236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
    Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
    Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters.
    Tseng YP; Kuo YH; Hu CP; Jeng KS; Janmanchi D; Lin CH; Chou CK; Yeh SF
    Antiviral Res; 2008 Mar; 77(3):206-14. PubMed ID: 18249449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication.
    Romero MR; Serrano MA; Efferth T; Alvarez M; Marin JJ
    Planta Med; 2007 Jun; 73(6):552-8. PubMed ID: 17458779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
    Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
    Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat shock protein 90 facilitates formation of the HBV capsid via interacting with the HBV core protein dimers.
    Shim HY; Quan X; Yi YS; Jung G
    Virology; 2011 Feb; 410(1):161-9. PubMed ID: 21126747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    J Viral Hepat; 2009 May; 16(5):367-75. PubMed ID: 19228285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis revealed that conservation of hepatitis B virus reverse transcriptase residue 306 (rtP306) is crucial for encapsidation of pregenomic RNA.
    Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
    FEBS Lett; 2007 Feb; 581(3):558-64. PubMed ID: 17254572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular virology and the development of resistant mutants: implications for therapy.
    Locarnini S
    Semin Liver Dis; 2005; 25 Suppl 1():9-19. PubMed ID: 16103977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C; Zoulim F
    Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.
    Asif-Ullah M; Choi KJ; Choi KI; Jeong YJ; Yu YG
    Antiviral Res; 2006 Jun; 70(2):85-90. PubMed ID: 16487605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein.
    Zheng Y; Fu XD; Ou JH
    Virology; 2005 Nov; 342(1):150-8. PubMed ID: 16122776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine.
    King RW; Ladner SK; Miller TJ; Zaifert K; Perni RB; Conway SC; Otto MJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3179-86. PubMed ID: 9835512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.
    Li J; Huang H; Feng M; Zhou W; Shi X; Zhou P
    Antiviral Res; 2008 Aug; 79(2):114-20. PubMed ID: 18423640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of hepatitis B virus replication by expression of polymerase-surface fusion protein through splicing: implications for viral persistence.
    Park GS; Kim HY; Shin HS; Park S; Shin HJ; Kim K
    Virus Res; 2008 Sep; 136(1-2):166-74. PubMed ID: 18562032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.